# Country Garden Venture Capital

> Country Garden Venture Capital is a VC fund backing Manufacturing. See 30 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Guangdong, China
- Total investments: 30
- Last investment: Jun 2023
- Lead investor: 37%
- Last updated: Aug 2026
- Website: https://cgvcap.com/

Country Garden Venture Capital is a VC fund in Guangdong focused on Manufacturing and Biotechnology. Country Garden Ventures was established in January 2019. It is a first-level business unit of Country Garden Group. It is responsible for the group's equity investment business in addition to real estate investment. Since its establishment, Country Garden Ventures has always adhered to the investment strategy of “industry empowerment andvalue co-creation”, paying equal attention to financial investment and holding investment, and has initially formed a staged, dedicated track, and multi-level investment portfolio. Up to now, the team has accumulatively invested in many star companies such as Shell Search, Qinhuai Data, Ziguang Zhanrui, Penguin Almond, Hobo Pharmaceutical, Blue Arrow Aerospace, Xinruipeng Pet Medical, Lin Qingxuan and so on.

## Contacts

5 contacts available for Country Garden Venture Capital. Shizune tracks 2 team members at Country Garden Venture Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/country-garden-venture-capital?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $10M–$16M |
| Series A | $1.5M–$1.5B |
| Series C | $105M–$563M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Manufacturing | 7 | 23% |
| Biotechnology | 4 | 13% |
| Retail | 3 | 10% |
| Medical | 3 | 10% |
| Health Care | 3 | 10% |

53 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 11 | 37% |
| Series C | 5 | 17% |
| Seed | 4 | 13% |
| Series B | 3 | 10% |
| Venture - Series Unknown | 3 | 10% |

8 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 25 | 83% |
| France | 1 | 3% |
| Germany | 1 | 3% |
| Hong Kong | 1 | 3% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Hao Du Andy | Managing Director | 1 | https://shizune.co/investors/profile/hao-du-andy |
| Niu Ruolei | managing partner | 1 | https://shizune.co/investors/profile/niu-ruolei |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| PCG Power | PCG Power's vision is to stick to its core business of distributed power station investment and the long-term development direction of new energy system solution providers, to provide comprehensive and high-quality green energy and carbon-saving services to industrial and commercial owners, and to assist my country in achieving carbon peakingand carbon neutrality. | $69.8M | Series A | Jun 13, 2023 |  |
| Zdeer | Zdeer is a health tech brand focusing on artificial intelligence health and consumer medicine. It is committed to improving the health awareness of the whole people, while breaking the shackles of the traditional health industry, through continuous technological innovation and product innovation, to bring better-looking and better-use products toconsumers at a more affordable price. |  | Series A | Jan 01, 2023 |  |
| Changjin Biotechnology | Changjin Biotechnology engages in the research, development, and industrialization of microbial synthetic proteins. | $22M | Series A | Jun 23, 2022 |  |
| HemaCell | Xueji Bio is a new cell therapy company founded by returnee experts to regenerate hematopoietic lineages (including blood cells and immune cells) in vitro, with unique stem cell reprogramming, editing and differentiation technologies. The company's unique iPSC establishment technology and gene targeting technology can quickly establish aplatform using platelet cells as a drug delivery carrier. |  | Series A | May 27, 2022 |  |
| China Resources Vanguard | China Resources Vanguard, doing business as China Resources Vanguard Shop or Vanguard, operates the supermarket chains of China Resources. It is the third-largest supermarket chain in Hong Kong. As of December 31, 2014, there are 4866 shops operating in Hong Kong and the mainland Chinese provinces/municipalities of Guangdong, Zhejiang,Jiangsu, Shanghai, Tianjin and Beijing.According to market research firm EuroMonitor's estimates in 2012, China Resources Vanguard supermarket market share in Hong Kong is about 7.8%. Wellcome Hong Kong's market share is about 39.8% and PARKnSHOP Hong Kong's market share is about 33.1%.On August 18, 2013, China Resources Enterprise's supermarket chain Vanguard and British supermarket Tesco signed a "memorandum of understanding", intending to set up a joint venture interest group in mainland China, Hong Kong and Macau, operating hypermarkets, supermarkets, convenience stores, liquor stores and cash and carry businesses. China Resources Enterprise took an 80% share and Tesco took a 20% share. | $400M | Venture - Series Unknown | Apr 21, 2022 |  |
| ACXEL Tech | ACXEL Tech develops large area electronics have given us flat panel displays and flexible, wearable devices. ACXEL takes these ‘active’ pixels and puts them to work transporting liquid droplets – precisely and at amazing speed.Millions of pixels are transformed into tiny engines moving samples around via a high throughput, low cost andprogrammable platform, offering a wide range of possibilities in chemistry, biology and medtech. | $10M | Seed | Mar 31, 2022 |  |
| SJ Semi | SJ Semi is a MEOL (Middle-End of Line) foundry which implements front-end wafer manufacturing and quality systems to MEOL operations. SJSemi's main business is providing bumping, Cu pillar, RDL, and testing services for 12" wafers. The company also places heavy R&D emphasis on fan-out, TSV, interposer, and 3D technologies. | $300M | Series C | Mar 18, 2022 |  |
| Zhongna Energy | Zhongna Energy is a research and development company of sodium-ion batteries. |  | Seed | Mar 04, 2022 |  |
| Zhongke Guosheng | Zhongke Guosheng is a bio-based materials R&D firm that designs and develops furan-based bio-based materials. | $1.6M | Angel | Feb 28, 2022 |  |
| HemaCell | Xueji Bio is a new cell therapy company founded by returnee experts to regenerate hematopoietic lineages (including blood cells and immune cells) in vitro, with unique stem cell reprogramming, editing and differentiation technologies. The company's unique iPSC establishment technology and gene targeting technology can quickly establish aplatform using platelet cells as a drug delivery carrier. | $15.8M | Seed | Feb 25, 2022 |  |

10 of 30 investments shown.

## Co-investors
- [Hillhouse Investment](https://shizune.co/investors/profile/hillhouse-investment) — VC Fund, 5 deals together
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund, 4 deals together
- [CICC](https://shizune.co/investors/profile/cicc) — VC Fund, 3 deals together
- [CPE](https://shizune.co/investors/profile/citic-pe) — VC Fund, 3 deals together
- [Poly Capital](https://shizune.co/investors/profile/poly-capital) — VC Fund, 3 deals together
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund, 3 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [Alexandria Venture Investments](https://shizune.co/investors/profile/alexandria-venture-investments) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [East Ventures](https://shizune.co/investors/profile/east-ventures) — VC Fund
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund

## Featured in investor lists
- [Wine And Spirits Investors in Asia](https://shizune.co/investors/wine-and-spirits-investors-asia)
- [Wine And Spirits VC Funds in Asia](https://shizune.co/investors/wine-and-spirits-vc-funds-asia)
- [Life Science Investors in China](https://shizune.co/investors/life-science-investors-china)
- [Life Science VC Funds in China](https://shizune.co/investors/life-science-vc-funds-china)
- [Construction VC Funds in China](https://shizune.co/investors/construction-vc-funds-china)
- [Life Science Investors in Asia](https://shizune.co/investors/life-science-investors-asia)

## FAQ

### What does Country Garden Venture Capital invest in?

Country Garden Venture Capital invests primarily in Manufacturing, Biotechnology and Retail startups, most often at Series A and Series C stage. Most of the 30 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Country Garden Venture Capital's check size?

Country Garden Venture Capital typically joins rounds of $10M–$16M at Seed, $1.5M–$1.5B at Series A and $105M–$563M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Country Garden Venture Capital participates in.

### How do I contact Country Garden Venture Capital?

Public channels for Country Garden Venture Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Country Garden Venture Capital?

The team at Country Garden Venture Capital includes Hao Du Andy (Managing Director) and Niu Ruolei (managing partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co